ESC 365 - Miss Shari Pepplinkhuizen

Speaker illustration

Miss Shari Pepplinkhuizen

Amsterdam University Medical Centre, Amsterdam (Netherlands (The))

Presentations Articles

Equal performance of the subcutaneous and transvenous implantable cardioverter defibrillator across all age groups in the PRAETORIAN trial

Event: ESC Congress 2024

Topic: Device Treatment

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Antithrombotic therapy and the risk of pocket hematoma after subcutaneous implantable cardioverter-defibrillator implantation

Event: ESC Congress 2024

Topic: Device Treatment

Session: Subcutaneous and extravascular defibrillators: already mainstream?

Clinical relevance of the single-lead ECG of the Apple Watch

Event: ESC Congress 2022

Topic: Remote Patient Monitoring and Telehealth

Session: e-Cardiology/Digital health - Remote monitoring 1

Mechanism, follow-up and recurrence of inappropriate therapy in the PRAETORIAN trial: action reduces recurrence

Event: EHRA 2022

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: ePosters Day 2

Exercise-optimised programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation of S-ICDs

Event: EHRA 2021

Topic: Genetic Aspects of Arrhythmias

Session: Scientific reports

Exercise-optimized programming after S-ICD implantation contributes to a lower risk of inappropriate shocks in the latest generation S-ICDs

Event: EHRA 2021

Topic: Implantable Cardioverter-Defibrillator (ICD)

Session: Oral abstract session - Devices

ESC 365 is supported by

Explore sponsored resources

Explore sponsored resources